Ongoing Airway Inflammation in Patients with COPD Who Do Not Currently Smoke

Overview

Journal Thorax

Date 1999 Dec 23

PMID 10607796

Citations 73

Authors

S R Rutgers

D S Postma

N H Ten Hacken

H F Kauffman

T W van der Mark

G H Koeter

W Timens

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory changes in the airways in chronic obstructive pulmonary disease (COPD) are largely attributed to smoking, yet they may be present even if patients do not currently smoke. The differences in inflammatory cells and the factors contributing to these differences were examined in the airways of patients with COPD who do not currently smoke.

Methods: Eighteen non-atopic subjects with COPD (14 men) of mean (SD) age 62 (8) years and forced expiratory volume in one second (FEV(1)) 59 (13)% predicted and 11 non-atopic healthy subjects (eight men) of mean (SD) age 58 (8) years, FEV(1) 104 (11)% predicted were studied. Sputum induction and bronchoscopy with bronchoalveolar lavage (BAL) and biopsies were performed.

Results: Patients with COPD had more mucosal EG2+ cells (eosinophils) (median (range) 40 (0-190) versus 5 (0-40) cells/mm(2), p = 0.049) and CD68+ cells (1115 (330-2920) versus 590 (450-1580) cells/mm(2), p = 0.03), and a tendency towards more CD4+ but not CD8+ lymphocytes than healthy controls. Furthermore, patients with COPD had higher percentages of sputum neutrophils (77 (29-94) versus 36 (18-60)%, p = 0.001) and eosinophils (1.2 (0-8.5) versus 0.2 (0-3.1)%, p = 0.008), BAL fluid eosinophils (0.4 (0-1.7) versus 0.2 (0-0.5)%, p = 0.03), and higher concentrations of sputum eosinophilic cationic protein (ECP) (838 (115-23 760) versus 121 (35-218) ng/ml, p<0.001). Concentrations of ECP expressed per eosinophil were not higher. Patients with COPD with high mucosal EG2+ cell numbers also had high mucosal CD4+ cell numbers. Sputum eosinophilia was associated with a decrease in FEV(1)/VC and BAL fluid eosinophilia with a decrease in mucosal NP57+ cells (neutrophils).

Conclusions: Subjects with COPD who do not currently smoke have increased numbers of inflammatory cells. Eosinophils are increased in number in the airways in COPD but do not seem to be activated. The increased eosinophil numbers are probably due to recruitment as a result of ongoing inflammation. Macrophages and lymphocytes may play a part in this inflammation.

Citing Articles

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).

Lai Y, Tsai Y, Hsieh M, Chen N, Cheng S, Tao C Respir Res. 2024; 25(1):377.

PMID: 39420386 PMC: 11487693. DOI: 10.1186/s12931-024-02971-3.

Novel DNA methylation changes in mouse lungs associated with chronic smoking.

Onuzulu C, Lee S, Basu S, Comte J, Hai Y, Hizon N Epigenetics. 2024; 19(1):2322386.

PMID: 38436597 PMC: 10913724. DOI: 10.1080/15592294.2024.2322386.

Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.

Dey S, Lu W, Haug G, Chia C, Larby J, Weber H Respir Res. 2023; 24(1):221.

PMID: 37700291 PMC: 10498556. DOI: 10.1186/s12931-023-02527-x.

Oxidative Stress-Derived Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: A Concise Review.

Antunes M, Lopes-Pacheco M, Rocco P Oxid Med Cell Longev. 2023; 2021:6644002.

PMID: 37448755 PMC: 10337713. DOI: 10.1155/2021/6644002.

MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease.

Fang C, Kang B, Zhao P, Ran J, Wang L, Zhao L Can Respir J. 2023; 2023:8659293.

PMID: 37200921 PMC: 10188265. DOI: 10.1155/2023/8659293.

References

Mueller R, Chanez P, Campbell A, Bousquet J, Heusser C, Bullock G . Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med. 1996; 90(2):79-85. DOI: 10.1016/s0954-6111(96)90202-4. View

Maestrelli P, Saetta M, Di Stefano A, Calcagni P, Turato G, Ruggieri M . Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med. 1995; 152(6 Pt 1):1926-31. DOI: 10.1164/ajrccm.152.6.8520757. View

OShaughnessy T, Ansari T, Barnes N, Jeffery P . Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997; 155(3):852-7. DOI: 10.1164/ajrccm.155.3.9117016. View

Saetta M, Di Stefano A, Turato G, Facchini F, Corbino L, Mapp C . CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(3 Pt 1):822-6. DOI: 10.1164/ajrccm.157.3.9709027. View

Lams B, Sousa A, Rees P, Lee T . Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 158(5 Pt 1):1518-23. DOI: 10.1164/ajrccm.158.5.9802121. View

Sibille Y, Reynolds H . Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990; 141(2):471-501. DOI: 10.1164/ajrccm/141.2.471. View

Miller L, Goldstein G, Murphy M, Ginns L . Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest. 1982; 82(5):526-9. DOI: 10.1378/chest.82.5.526. View

Hughes D, Haslam P, Townsend P, TURNER-WARWICK M . Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol. 1985; 61(2):459-66. PMC: 1577295. View

Garcia-Sanz J, Velotti F, MacDonald H, Masson D, Tschopp J, Nabholz M . Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli. Immunology. 1988; 64(1):129-34. PMC: 1385197. View

10.

Baggiolini M, Walz A, Kunkel S . Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989; 84(4):1045-9. PMC: 329758. DOI: 10.1172/JCI114265. View

11.

Thompson A, Daughton D, Robbins R, Ghafouri M, Oehlerking M, Rennard S . Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 1989; 140(6):1527-37. DOI: 10.1164/ajrccm/140.6.1527. View

12.

Burke W, Roberts C, Bryant D, Cairns D, Yeates M, Morgan G . Smoking-induced changes in epithelial lining fluid volume, cell density and protein. Eur Respir J. 1992; 5(7):780-4. View

13.

Turnbull L, Turnbull L, Leitch A, Crofton J, Kay A . Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet. 1977; 2(8037):526-9. DOI: 10.1016/s0140-6736(77)90664-x. View

14.

Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A . Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993; 147(2):301-6. DOI: 10.1164/ajrccm/147.2.301. View

15.

Di Stefano A, Turato G, Maestrelli P, Mapp C, Ruggieri M, Roggeri A . Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med. 1996; 153(2):629-32. DOI: 10.1164/ajrccm.153.2.8564109. View

16.

Quanjer P, Tammeling G, Cotes J, Pedersen O, Peslin R, Yernault J . Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16:5-40. View

17.

Lacoste J, Bousquet J, Chanez P, van Vyve T, Simony-Lafontaine J, Lequeu N . Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993; 92(4):537-48. DOI: 10.1016/0091-6749(93)90078-t. View

18.

Pilewski J, Albelda S . Adhesion molecules in the lung. An overview. Am Rev Respir Dis. 1993; 148(6 Pt 2):S31-7. DOI: 10.1164/ajrccm/148.6_Pt_2.S31. View

19.

Agostini C, Chilosi M, Zambello R, Trentin L, Semenzato G . Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J. 1993; 6(9):1378-401. View

20.

Sibille Y, Marchandise F . Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J. 1993; 6(10):1529-43. View